Cardiac effects of therapy with lithium: An enzymatic study

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Prophylactic therapy with lithium has been associated with various side effects on different organ systems, but any direct relationship between chronic therapy with lithium and myocardial injury has yet to be firmly established. We evaluated a group of 89 patients being treated with lithium for myocardial injury as suggested by increases in total creatine kinase (CK) and creatine kinase-MB (CK-MB) activity in serum of two of six patients with lithium toxicity who had such increases. Three others with therapeutic lithium concentrations in their serum also showed increased CK and CK-MB activity. Myocardial injury, with subsequent release of CK and CK-MB into the circulation, is not uncommon in patients with lithium toxicity. The duration and the degree of lithium toxicity appear to be important factors affecting release of CK and CK-MB. Patients with therapeutic concentrations of lithium may also be at risk for myocardial injury with release of CK and CK-MB into the serum, especially if on long-term treatment with lithium and if older than 60 years.

Original languageEnglish (US)
Pages (from-to)157-161
Number of pages5
JournalLithium
Volume1
Issue number3
StatePublished - 1990
Externally publishedYes

Fingerprint

Lithium
MB Form Creatine Kinase
Creatine Kinase
Therapeutics
Wounds and Injuries
Serum

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Cardiac effects of therapy with lithium : An enzymatic study. / Kazmierczak, Steven (Steve); Van Lente, F.

In: Lithium, Vol. 1, No. 3, 1990, p. 157-161.

Research output: Contribution to journalArticle

Kazmierczak, SS & Van Lente, F 1990, 'Cardiac effects of therapy with lithium: An enzymatic study', Lithium, vol. 1, no. 3, pp. 157-161.
@article{de7be78948d84274961fe048a8b2af33,
title = "Cardiac effects of therapy with lithium: An enzymatic study",
abstract = "Prophylactic therapy with lithium has been associated with various side effects on different organ systems, but any direct relationship between chronic therapy with lithium and myocardial injury has yet to be firmly established. We evaluated a group of 89 patients being treated with lithium for myocardial injury as suggested by increases in total creatine kinase (CK) and creatine kinase-MB (CK-MB) activity in serum of two of six patients with lithium toxicity who had such increases. Three others with therapeutic lithium concentrations in their serum also showed increased CK and CK-MB activity. Myocardial injury, with subsequent release of CK and CK-MB into the circulation, is not uncommon in patients with lithium toxicity. The duration and the degree of lithium toxicity appear to be important factors affecting release of CK and CK-MB. Patients with therapeutic concentrations of lithium may also be at risk for myocardial injury with release of CK and CK-MB into the serum, especially if on long-term treatment with lithium and if older than 60 years.",
author = "Kazmierczak, {Steven (Steve)} and {Van Lente}, F.",
year = "1990",
language = "English (US)",
volume = "1",
pages = "157--161",
journal = "Lithium",
issn = "0954-1381",
number = "3",

}

TY - JOUR

T1 - Cardiac effects of therapy with lithium

T2 - An enzymatic study

AU - Kazmierczak, Steven (Steve)

AU - Van Lente, F.

PY - 1990

Y1 - 1990

N2 - Prophylactic therapy with lithium has been associated with various side effects on different organ systems, but any direct relationship between chronic therapy with lithium and myocardial injury has yet to be firmly established. We evaluated a group of 89 patients being treated with lithium for myocardial injury as suggested by increases in total creatine kinase (CK) and creatine kinase-MB (CK-MB) activity in serum of two of six patients with lithium toxicity who had such increases. Three others with therapeutic lithium concentrations in their serum also showed increased CK and CK-MB activity. Myocardial injury, with subsequent release of CK and CK-MB into the circulation, is not uncommon in patients with lithium toxicity. The duration and the degree of lithium toxicity appear to be important factors affecting release of CK and CK-MB. Patients with therapeutic concentrations of lithium may also be at risk for myocardial injury with release of CK and CK-MB into the serum, especially if on long-term treatment with lithium and if older than 60 years.

AB - Prophylactic therapy with lithium has been associated with various side effects on different organ systems, but any direct relationship between chronic therapy with lithium and myocardial injury has yet to be firmly established. We evaluated a group of 89 patients being treated with lithium for myocardial injury as suggested by increases in total creatine kinase (CK) and creatine kinase-MB (CK-MB) activity in serum of two of six patients with lithium toxicity who had such increases. Three others with therapeutic lithium concentrations in their serum also showed increased CK and CK-MB activity. Myocardial injury, with subsequent release of CK and CK-MB into the circulation, is not uncommon in patients with lithium toxicity. The duration and the degree of lithium toxicity appear to be important factors affecting release of CK and CK-MB. Patients with therapeutic concentrations of lithium may also be at risk for myocardial injury with release of CK and CK-MB into the serum, especially if on long-term treatment with lithium and if older than 60 years.

UR - http://www.scopus.com/inward/record.url?scp=0025534238&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025534238&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0025534238

VL - 1

SP - 157

EP - 161

JO - Lithium

JF - Lithium

SN - 0954-1381

IS - 3

ER -